195 related articles for article (PubMed ID: 24305710)
21. The Presence and Potential Role of ALDH1A2 in the Glioblastoma Microenvironment.
Sanders S; Herpai DM; Rodriguez A; Huang Y; Chou J; Hsu FC; Seals D; Mott R; Miller LD; Debinski W
Cells; 2021 Sep; 10(9):. PubMed ID: 34572134
[TBL] [Abstract][Full Text] [Related]
22. MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma.
Li G; Ma L; Feng C; Yin H; Bao J; Wu D; Zhang Z; Li X; Li Z; Yang C; Wang H; Fang F; Hu X; Li M; Xu L; Xu Y; Liang H; Yang T; Wang J; Pan J
BMC Cancer; 2024 Feb; 24(1):220. PubMed ID: 38365636
[TBL] [Abstract][Full Text] [Related]
23. KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice.
Polson ES; Kuchler VB; Abbosh C; Ross EM; Mathew RK; Beard HA; da Silva B; Holding AN; Ballereau S; Chuntharpursat-Bon E; Williams J; Griffiths HBS; Shao H; Patel A; Davies AJ; Droop A; Chumas P; Short SC; Lorger M; Gestwicki JE; Roberts LD; Bon RS; Allison SJ; Zhu S; Markowetz F; Wurdak H
Sci Transl Med; 2018 Aug; 10(454):. PubMed ID: 30111643
[TBL] [Abstract][Full Text] [Related]
24. Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression.
Qi Q; Kang SS; Zhang S; Pham C; Fu H; Brat DJ; Ye K
Oncogene; 2017 Aug; 36(32):4562-4572. PubMed ID: 28368413
[TBL] [Abstract][Full Text] [Related]
25. Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma.
Stringer BW; Bunt J; Day BW; Barry G; Jamieson PR; Ensbey KS; Bruce ZC; Goasdoué K; Vidal H; Charmsaz S; Smith FM; Cooper LT; Piper M; Boyd AW; Richards LJ
Oncotarget; 2016 May; 7(20):29306-20. PubMed ID: 27083054
[TBL] [Abstract][Full Text] [Related]
26. Aquaporin 1 elicits cell motility and coordinates vascular bed formation by downregulating thrombospondin type-1 domain-containing 7A in glioblastoma.
Oishi M; Munesue S; Harashima A; Nakada M; Yamamoto Y; Hayashi Y
Cancer Med; 2020 Jun; 9(11):3904-3917. PubMed ID: 32253832
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA 3928 Suppresses Glioblastoma through Downregulation of Several Oncogenes and Upregulation of p53.
Mulcahy EQX; Zhang Y; Colόn RR; Cain SR; Gibert MK; Dube CJ; Hafner M; Abounader R
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409289
[TBL] [Abstract][Full Text] [Related]
28. EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma.
Ding J; Li X; Khan S; Zhang C; Gao F; Sen S; Wasylishen AR; Zhao Y; Lozano G; Koul D; Alfred Yung WK
Neuro Oncol; 2022 Oct; 24(10):1712-1725. PubMed ID: 35474131
[TBL] [Abstract][Full Text] [Related]
29. p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation.
Panicker SP; Raychaudhuri B; Sharma P; Tipps R; Mazumdar T; Mal AK; Palomo JM; Vogelbaum MA; Haque SJ
Oncotarget; 2010 Aug; 1(4):289-303. PubMed ID: 21304179
[TBL] [Abstract][Full Text] [Related]
30. Restoration of endogenous wild-type p53 activity in a glioblastoma cell line with intrinsic temperature-sensitive p53 induces growth arrest but not apoptosis.
Ikeda J; Tada M; Ishii N; Saya H; Tsuchiya K; Okaichi K; Mishima K; Sawamura Y; Fulci G; Liu TJ; Van Meir EG
Int J Cancer; 2001 Oct; 94(1):35-43. PubMed ID: 11668476
[TBL] [Abstract][Full Text] [Related]
31. SIRT2-mediated inactivation of p73 is required for glioblastoma tumorigenicity.
Funato K; Hayashi T; Echizen K; Negishi L; Shimizu N; Koyama-Nasu R; Nasu-Nishimura Y; Morishita Y; Tabar V; Todo T; Ino Y; Mukasa A; Saito N; Akiyama T
EMBO Rep; 2018 Nov; 19(11):. PubMed ID: 30213795
[TBL] [Abstract][Full Text] [Related]
32. TPPP3 promote epithelial-mesenchymal transition via Snail1 in glioblastoma.
Xu X; Hou Y; Long N; Jiang L; Yan Z; Xu Y; Lv Y; Xiang X; Yang H; Liu J; Qi X; Chu L
Sci Rep; 2023 Oct; 13(1):17960. PubMed ID: 37863960
[TBL] [Abstract][Full Text] [Related]
33. Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/STAT3 axis.
Qiu Y; Pei D; Wang M; Wang Q; Duan W; Wang L; Liu K; Guo Y; Luo L; Guo Z; Guan F; Wang Z; Xing A; Liu Z; Ma Z; Jiang G; Yan D; Liu X; Zhang Z; Wang W
CNS Neurosci Ther; 2024 Apr; 30(4):e14709. PubMed ID: 38605477
[TBL] [Abstract][Full Text] [Related]
34. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.
Tardito S; Oudin A; Ahmed SU; Fack F; Keunen O; Zheng L; Miletic H; Sakariassen PØ; Weinstock A; Wagner A; Lindsay SL; Hock AK; Barnett SC; Ruppin E; Mørkve SH; Lund-Johansen M; Chalmers AJ; Bjerkvig R; Niclou SP; Gottlieb E
Nat Cell Biol; 2015 Dec; 17(12):1556-68. PubMed ID: 26595383
[TBL] [Abstract][Full Text] [Related]
35. PIP4K2A as a negative regulator of PI3K in PTEN
Shin YJ; Sa JK; Lee Y; Kim D; Chang N; Cho HJ; Son M; Oh MYT; Shin K; Lee JK; Park J; Jo YK; Kim M; Paddison PJ; Tergaonkar V; Lee J; Nam DH
J Exp Med; 2019 May; 216(5):1120-1134. PubMed ID: 30898893
[TBL] [Abstract][Full Text] [Related]
36. Nestin Is Required for Spindle Assembly and Cell-Cycle Progression in Glioblastoma Cells.
Wang Q; Wu H; Hu J; Fu H; Qu Y; Yang Y; Cai KQ; Efimov A; Wu M; Yen T; Wang Y; Yang ZJ
Mol Cancer Res; 2021 Oct; 19(10):1651-1665. PubMed ID: 34158391
[TBL] [Abstract][Full Text] [Related]
37. The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation.
Kosti A; de Araujo PR; Li WQ; Guardia GDA; Chiou J; Yi C; Ray D; Meliso F; Li YM; Delambre T; Qiao M; Burns SS; Lorbeer FK; Georgi F; Flosbach M; Klinnert S; Jenseit A; Lei X; Sandoval CR; Ha K; Zheng H; Pandey R; Gruslova A; Gupta YK; Brenner A; Kokovay E; Hughes TR; Morris QD; Galante PAF; Tiziani S; Penalva LOF
Genome Biol; 2020 Aug; 21(1):195. PubMed ID: 32762776
[TBL] [Abstract][Full Text] [Related]
38. A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma.
Johansson P; Krona C; Kundu S; Doroszko M; Baskaran S; Schmidt L; Vinel C; Almstedt E; Elgendy R; Elfineh L; Gallant C; Lundsten S; Ferrer Gago FJ; Hakkarainen A; Sipilä P; Häggblad M; Martens U; Lundgren B; Frigault MM; Lane DP; Swartling FJ; Uhrbom L; Nestor M; Marino S; Nelander S
Cell Rep; 2020 Jul; 32(2):107897. PubMed ID: 32668248
[TBL] [Abstract][Full Text] [Related]
39. Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastoma.
Lara-Velazquez M; Zarco N; Carrano A; Phillipps J; Norton ES; Schiapparelli P; Al-Kharboosh R; Rincon-Torroella J; Jeanneret S; Corona T; Segovia J; Jentoft ME; Chaichana KL; Asmann YW; Quiñones-Hinojosa A; Guerrero-Cazares H
Neuro Oncol; 2021 Apr; 23(4):599-610. PubMed ID: 33249487
[TBL] [Abstract][Full Text] [Related]
40. POLE2 facilitates the malignant phenotypes of glioblastoma through promoting AURKA-mediated stabilization of FOXM1.
Zhang P; Chen X; Zhang L; Cao D; Chen Y; Guo Z; Chen J
Cell Death Dis; 2022 Jan; 13(1):61. PubMed ID: 35039475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
